QYH Biotech Co., Ltd. (hereinafter referred to as “QYH”) was jointly initiated by five shareholders, including China Animal Husbandry Industry Co., Ltd., Beijing Zhonghai Biotech Co., Ltd., Yunnan Veterinary Biological Products Research Center, China Animal Husbandry Group and China Agricultural University, and approved by the State-owned Assets Supervision and Administration Commission of the State Council. It was officially registered with the State Administration for Industry and Commerce on July 1, 2004, with a registered capital of 248 million yuan, and mainly engaged in the production, sales, research and development, technical services, project investment and import and export trade of veterinary biological products and diagnostic reagents.
QYH is a manufacturer specializing in the production of highly pathogenic avian influenza; Respiratory Syndrome(PRRS) and other major animal disease vaccines, and has made outstanding contributions in the prevention and control of major animal diseases such as avian influenza and foot-and-mouth disease. It owns three GMP production bases with international advanced technology level - Nanjing Biopharmaceutical Factory, Zhengzhou Biopharmaceutical Factory, Beijing Biopharmaceutical Factory. Nanjing Biopharmaceutical Factory can be traced back to 1931, which is the first domestic veterinary biological product manufacturer; Zhengzhou Biopharmaceutical Factory was established in 1949, and is the first in China to realize the industrial production of avian influenza vaccine; Beijing Biopharmaceutical Factory was established in 1988 and is in the “Top Ten Small Innovation Enterprise” in Zhongguancun High-tech Park.
QYHcurrently produces nearly 60 varieties of veterinary biological products and diagnostic reagents, more than 200 specifications, with an annual output of nearly 20 billion doses (heads) animal vaccines. The domestic market share of products ranks among the top in the industry. The company's products have been exported to Indonesia, Egypt, Vietnam, Mongolia and other countries, and established economic and trade cooperation with Africa, Southeast Asia and neighboring countries.
QYH is a high-tech enterprise in Beijing, and it was awarded the 4th China Advanced Animal Husbandry Enterprise, National Animal Husbandry Integrity Benchmarking Enterprise, Animal Husbandry Economy Leading Enterprise, National Poultry Industry Association CAAA, CHINA Contribution Award, and Top Ten Biopharmaceutical Enterprises, China's top 50 veterinary drug manufacturers, top 10 veterinary biological products companies, China's animal health products impact brand, 20 major technology breakthrough veterinary biological products brand, Beijing famous brand.
QYHhas promoted the development of enterprises with scientific and technological innovation, and it has won more than 20 national and provincial-level science and technology awards, with outstanding brand advantage. QYH is committed to becoming a leader in China's poultry bio-products industry, a world-class veterinary bio-products company, and a century-old store with a long history.